Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-09-18 07:00 |
Valneva annonce le départ à la retraite de son directeur financier David Lawren…
|
French | 376.3 KB | ||
| 2020-09-14 07:00 |
Valneva and Dynavax Announce Commercial Supply Agreement for Inactivated, Adjuv…
|
English | 476.7 KB | ||
| 2020-09-14 07:00 |
Valneva annonce un partenariat majeur avec le gouvernement britannique pour son…
|
French | 640.8 KB | ||
| 2020-09-14 07:00 |
Valneva et Dynavax annoncent un partenariat commercial pour un vaccin inactivé,…
|
French | 555.4 KB | ||
| 2020-09-14 07:00 |
Valneva Announces Major COVID-19 Vaccine Partnership with U.K. Government
|
English | 560.1 KB | ||
| 2020-09-09 18:30 |
Valneva conclut un nouveau contrat d’une valeur maximale de $166 millions avec …
|
French | 518.1 KB | ||
| 2020-09-09 18:30 |
Valneva Announces New IXIARO® Supply Contract with the US Government worth up t…
|
English | 311.0 KB | ||
| 2020-09-08 07:00 |
Valneva Initiates Phase 3 Clinical Study for its Chikungunya Vaccine Candidate …
|
English | 577.6 KB | ||
| 2020-09-08 07:00 |
Valneva initie l’étude clinique de Phase 3 de son candidat vaccin contre le chi…
|
French | 782.4 KB | ||
| 2020-09-03 18:00 |
Valneva - Déclaration d’actions et de droits de vote – AOUT 2020
|
English | 205.2 KB | ||
| 2020-08-07 18:00 |
Valneva - Déclaration d’actions et de droits de vote – JUILLET 2020
|
English | 16.6 KB | ||
| 2020-08-06 07:00 |
Valneva Announces Appointment of Juan Carlos Jaramillo as Chief Medical Officer
|
English | 306.9 KB | ||
| 2020-08-06 07:00 |
Valneva annonce la nomination de Juan Carlos Jaramillo comme Directeur Médical
|
French | 429.4 KB | ||
| 2020-08-04 17:11 |
VALNEVA : Rapport Semestriel 2020
|
French | 810.3 KB | ||
| 2020-08-04 07:00 |
Valneva publie ses résultats du S1 2020 marqués par des avancées majeures et un…
|
French | 735.7 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
